The issue of necrotizing enterocolitis (NEC) in premature infants has led to a wave of lawsuits against Mead Johnson, the manufacturer of Enfamil, with claims that the company failed to adequately warn about the risks associated with their products.
Written by :
Gregory Parker
Edited by :
Grace Johnson
Judge Rebecca Pallmeyer issued a significant ruling requiring plaintiffs in the multidistrict litigation against Mead Johnson to present concrete evidence that an infant consumed Enfamil or another Mead Johnson product. This ruling aims to ensure that only cases with direct connections to the product are allowed to proceed, potentially reducing the number of frivolous lawsuits and focusing on legitimate claims.
In a landmark decision, an Illinois jury awarded $60 million to the mother of a premature infant who died from necrotizing enterocolitis (NEC) after being fed Enfamil, a product of Mead Johnson. The jury found the company responsible for failing to warn about the risks associated with their formula for preterm infants. This verdict underscores the severe consequences of NEC and highlights the ongoing legal challenges faced by Mead Johnson.
Attorneys for both sides continued to negotiate the terms of the discovery process, which involves the exchange of relevant information and evidence before the trial. The parties were required to submit a brief on any unresolved discovery issues to the court by April 25, 2023. This stage is crucial for building the cases, as it involves gathering electronic communications, internal documents, and other critical data.
Judge Pallmeyer scheduled a "Science Day" for May 3, 2023, allowing both parties to present general medical and scientific issues to the court. This event helps the court understand the complex scientific background related to NEC and the alleged risks posed by cow's milk-based formulas, which is essential for informed decision-making in the litigation process.
The selection of bellwether cases was completed. Both defendants and plaintiffs selected potential cases, including Clarke, Cresap, Inman, Mar, Brown, Diggs, Lopez, and Koeth. Additionally, randomly selected cases included McCarthy, Jacobs, Kelton, and Donaldson. These cases are expected to provide insight into how juries might respond to evidence in the broader litigation.
The Enfamil baby formula lawsuits are centered around serious health concerns, particularly the risk of necrotizing enterocolitis in premature infants. NEC is a life-threatening intestinal disease that predominantly affects preterm babies. It leads to the inflammation and death of intestinal tissue, which can cause severe infections and, in many cases, be fatal.
The core allegation in the lawsuits is that Mead Johnson, the manufacturer of Enfamil, failed to adequately warn parents and healthcare providers about the heightened risk of NEC associated with their cow's milk-based formulas.
Research has demonstrated that NEC is significantly more common in formula-fed preterm infants compared to those who are breastfed. Specifically, a study published in The Lancet in 1990 found that NEC was six to ten times more likely to occur in exclusively formula-fed babies than in those fed breast milk. [1]
Additionally, numerous other studies have underscored the dangers of feeding cow's milk-based formulas to premature infants. For instance, a study in The Journal of Pediatrics found that preemies fed an exclusively human milk-based diet were 90% less likely to develop surgical NEC compared to those fed a diet that included bovine milk-based products. [2]
Finally, major health organizations, like the World Health Organization and the American Academy of Pediatrics, have consistently recommended feeding preterm infants with human milk due to its lower associated risks. This consensus among experts further emphasizes the link between cow's milk-based formulas like Enfamil and the increased risk of NEC.
Identifying the specific Enfamil products named in these lawsuits can provide a clearer picture of the scope of the allegations. Let’s shift our focus to the particular cow's milk-based formulas named in these lawsuits and their role in the increased risk of NEC among premature infants.
The following Enfamil products have been specifically named in lawsuits due to their association with an increased risk of necrotizing enterocolitis in premature infants:
These products have been highlighted in numerous NEC baby formula lawsuits because they are cow's milk-based formulas, which studies have linked to a higher incidence of NEC in preterm infants.
The fact that so many different products are involved underscores the breadth of the issue and suggests that the risk associated with cow's milk-based formulas may be widespread across different types and formulations of Enfamil products.
This broad implication indicates a significant concern for the safety of preterm infants and reinforces the need for thorough examination and possible reform in the formulation and marketing of these products.
Enfamil has experienced several recalls over the years. In February 2023, Reckitt recalled two batches of ProSobee Simply Plant-Based Infant Formula due to potential contamination with Cronobacter sakazakii, a dangerous bacteria.
Although tests showed no contamination, the recall was a precaution after identifying potential cross-contamination from a third-party supplier. This affected around 145,000 cans distributed in the US, Guam, and Puerto Rico, with no reported illnesses. [3]
Additionally, in early 2024, certain batches of Nutramigen Hypoallergenic Infant Formula Powder were also recalled due to possible bacterial contamination. Consumers were advised to check lot numbers, contact Enfamil for refunds, and safely dispose of the affected products. [4]
It's important to note that these recalls were not related to the allegations in the current lawsuits concerning NEC. They were precautionary measures addressing potential bacterial contamination, not the risks associated with cow's milk-based formulas leading to NEC.
To understand the gravity of the situation and the potential outcomes for the affected families, we need to examine the details of the Enfamil baby formula cases and the ongoing legal proceedings. The following section will delve into the specifics of these lawsuits and the current status of settlement negotiations.
As of May 2024, there are approximately 496 NEC-related lawsuits consolidated in an MDL under US District Judge Rebecca R. Pallmeyer in Illinois. These lawsuits claim that Mead Johnson, the manufacturer of Enfamil, failed to warn about the risks of NEC associated with their cow's milk-based formulas.
One of the landmark verdicts in these cases occurred in March 2024, when an Illinois jury awarded $60 million to the mother of a premature infant who died from NEC after being fed Enfamil. This verdict highlights the severity of the allegations and the potential financial repercussions for Mead Johnson. [5]
The jury found that the company was negligent and failed to provide adequate warnings about the risks of feeding their formula to premature infants. This substantial award is likely to influence ongoing settlement negotiations and future trial outcomes.
While there have been no global settlements in the MDL yet, the first bellwether trials are expected to provide a clearer indication of potential settlement values.
Lawyers speculate that individual lawsuit settlements could range from millions to tens of millions of dollars, depending on the specifics of each case, such as the severity of the injury and the financial and emotional impact on the families involved.
The ongoing legal proceedings are expected to grow, with more families filing claims as awareness of the potential risks becomes more widespread.
There is a notable difference between trial and settlement values in the Enfamil baby formula lawsuits. Trial values tend to be significantly higher because they are determined by a jury that evaluates the evidence and can award substantial damages if negligence is found, reflecting the severity of the injury and the impact on the plaintiffs.
However, trials come with high risks and uncertainty for both parties, as there is no guaranteed outcome and the legal process can be prolonged and expensive.
On the other hand, settlements provide a more predictable and controlled resolution, where both parties agree on a compensation amount without the uncertainties of a trial.
Settlements are generally lower than potential trial verdicts but offer quicker and guaranteed compensation, making them appealing for both plaintiffs, who benefit from immediate relief, and defendants, who can manage their financial risk and avoid adverse publicity.
The deadline to file an Enfamil baby formula lawsuit, commonly referred to as the statute of limitations, varies by state but generally falls within 2-3 years from the date of the incident. This means that parents or guardians must file a lawsuit within this timeframe after their child has been diagnosed with NEC potentially linked to Enfamil.
In many states, there is also a "discovery rule" that allows the statute of limitations to begin at the time when the parents or guardians discovered, or should have discovered, that the cow's milk-based formula could have caused NEC. This rule acknowledges that the connection between the formula and the condition may not be immediately apparent.
It's important to consult with an experienced legal professional as soon as possible to ensure that you meet all the legal deadlines and to preserve the integrity of your case. Product liability lawyers can provide guidance on the specific statute of limitations in your state and help gather the necessary evidence to support your claim.
While Enfamil formula is not intended to cause any harm, there are studies that suggest a potential link between the use of certain cow milk-based infant formulas, including Enfamil, and an increased risk of NEC in premature infants.
None of the Enfamil products have been recalled due to NEC. However, ProSobee Simply Plant-Based Infant Formula was recalled in 2023 for potential Cronobacter sakazakii contamination, and Nutramigen Hypoallergenic Infant Formula was recalled in 2024 for possible bacterial contamination.
Both the Enfamil and the Similac baby formula lawsuit involve several cow's milk-based formulas linked to an increased risk of NEC in premature infants. There is a long list of products alleged to increase the risk of NEC and includes various formulations marketed for preterm and low birth weight infants.
Submit your inquiry through our contact form to start your search for legal assistance. Our directory connects you with experienced lawyers in a variety of practice areas, ensuring you have access to advice when you need it most.
Don’t have an account? Sign up
Defective Medical Device Lawsuits 
Product Liability Lawsuits 
Sign up using your Google account
Sign up using your LinkedIn account